NUCLEOLIN and colorectal cancer: An MTT assay showed that the nucleolin-positive HT29 and C26 colorectal cancer cell lines were more sensitive to the targeted CPA-loaded pegylated dendrimers than the nucleolin-negative CHO cell line.